Diagnosing bipolar disorder and attention-deficit/hyperactivity disorder Elizabeth B. WellerRonald A. Weller Invited Commentary Pages: 81 - 82
Fluoxetine to prevent relapse of depression in children and adolescents Elizabeth B. WellerRonald A. Weller Clinical Trials Report Pages: 88 - 89
A biologic model to study the genetics of psychotic, mood, and anxiety disorders: The velocardiofacial syndrome Edith M. JolinElizabeth B. WellerRonald A. Weller OriginalPaper Pages: 90 - 95
Velocardiofacial syndrome: Is there a neuropsychiatric phenotype? Edith M. JolinElizabeth B. WellerRonald A. Weller OriginalPaper Pages: 96 - 101
Prevalence of ADHD in children with velocardiofacial syndrome: A preliminary report Karen ZagurskyRonald A. WellerElizabeth B. Weller OriginalPaper Pages: 102 - 107
Depression in children and adolescents: Does gender make a difference? Elizabeth B. WellerAngelica KloosRonald A. Weller OriginalPaper Pages: 108 - 114
Children’s reactions to parental and sibling death Aradhana Bela SoodAmit RazdanRonald A. Weller OriginalPaper Pages: 115 - 120
Prepubertal depression: Diagnostic and therapeutic dilemmas Roomana M. SheikhElizabeth B. WellerRonald A. Weller OriginalPaper Pages: 121 - 126
A cannabinoid-1 receptor antagonist to treat obesity Joseph F. Cubells Clinical Trials Report Pages: 129 - 130
Beyond the DSM: Defining endophenotypes for genetic studies of substance abuse Jon A. FrederickWilliam G. Iacono OriginalPaper Pages: 144 - 150
